Heritage Pharmaceuticals Recalls Acyclovir Tablets Due to Labeling Errors
Heritage Pharmaceuticals is recalling 408 bottles of Acyclovir 400 mg tablets distributed in Ohio due to incorrect or missing lot and expiration dates.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The hazard is limited to documentation issues (labeling errors).
Plain-English summary
Heritage Pharmaceuticals Inc. is recalling 408 bottles of Acyclovir Tablets, USP, 400 mg. The product is distributed by Avet Pharmaceuticals Inc. and is identified by NDC 23155-227-01. The affected units are packaged in 150 cc white HDPE bottles.
The recall was initiated because the product has incorrect or missing lot and/or expiration dates. The specific lot number is A120036, with an expiration date of December 2023. The distribution pattern indicates the product was distributed in Ohio (OH).
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance. The recall is classified as Class III by the FDA, indicating that the use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- ACYCLOVIR (ACYCLOVIR)
- Brand
- ACYCLOVIR
- Manufacturer
- Heritage Pharmaceuticals Inc
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 408
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot A120036
- Exp DEC 2023
UPCs (2)
- 0323155227017
- 0323155228014
Distribution
Distributed in 1 state:
Related recalls
Same brand · ACYCLOVIR
- SevereZydus Recalls Acyclovir Sodium Injection Due to Crystallization
FDA (Drugs) · 2021-04-07
- SevereZydus Recalls Acyclovir Sodium Injection Due to Crystallization
FDA (Drugs) · 2021-04-07
- SevereZydus Recalls Acyclovir Tablets Due to Labeling Error with Carvedilol
FDA (Drugs) · 2019-05-15
- SevereAcyclovir Tablets Recalled Due to Presence of Torsemide Tablets
FDA (Drugs) · 2018-03-07
- LowHetero USA Recalls Acyclovir Tablets Due to Human Hair Presence
FDA (Drugs) · 2017-06-14
Same manufacturer · Heritage Pharmaceuticals Inc
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighDesipramine 25 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine 75 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine 50 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine tablets recalled over nitrosamine impurity above acceptable daily intake
FDA (Drugs) · 2025-11-05
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02